Goldblum OM - Search Results

1

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.

Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM. Menter A, et al. Among authors: goldblum om. J Am Acad Dermatol. 2010 Sep;63(3):448-56. doi: 10.1016/j.jaad.2009.09.040. Epub 2010 Jun 3. J Am Acad Dermatol. 2010. PMID: 20605254 Clinical Trial.

2

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M. Langley RGB, et al. Qual Life Res. 2020 Feb;29(2):369-380. doi: 10.1007/s11136-019-02296-5. Epub 2019 Oct 26. Qual Life Res. 2020. PMID: 31655974 Clinical Trial.

3

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.

Leonardi C, Maari C, Philipp S, Goldblum O, Zhang L, Burkhardt N, Ball S, Mallbris L, Gonzalez P, Fernández-Peñas P, Puig L. Leonardi C, et al. J Am Acad Dermatol. 2018 Nov;79(5):824-830.e2. doi: 10.1016/j.jaad.2018.05.032. Epub 2018 May 25. J Am Acad Dermatol. 2018. PMID: 29803904 Clinical Trial.

4

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis.

Grace E, Goldblum O, Renda L, Agada N, See K, Leonardi C, Menter A. Grace E, et al. Dermatol Ther (Heidelb). 2020 Feb;10(1):99-106. doi: 10.1007/s13555-019-00341-2. Epub 2019 Nov 16. Dermatol Ther (Heidelb). 2020. PMID: 31734937 Free PMC article.

5

Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.

Langley RG, Rich P, Menter A, Krueger G, Goldblum O, Dutronc Y, Zhu B, Wei H, Cameron GS, Heffernan MP. Langley RG, et al. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1763-70. doi: 10.1111/jdv.12996. Epub 2015 Feb 18. J Eur Acad Dermatol Venereol. 2015. PMID: 25693783 Clinical Trial.

6

Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).

Reich K, Leonardi C, Lebwohl M, Kerdel F, Okubo Y, Romiti R, Goldblum O, Dennehy EB, Kerr L, Sofen H. Reich K, et al. J Dermatolog Treat. 2017 Jun;28(4):282-287. doi: 10.1080/09546634.2016.1249820. Epub 2016 Nov 13. J Dermatolog Treat. 2017. PMID: 27759463 Free article. Clinical Trial.

7

Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool.

Leonardi C, See K, Gallo G, McKean-Matthews M, Zhang Y, Goldblum O, Mallbris L, Burge R. Leonardi C, et al. Dermatol Ther (Heidelb). 2021 Aug;11(4):1249-1263. doi: 10.1007/s13555-021-00544-6. Epub 2021 May 28. Dermatol Ther (Heidelb). 2021. PMID: 34047947 Free PMC article.

8

Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3.

Egeberg A, Wu JJ, Korman N, Solomon JA, Goldblum O, Zhao F, Mallbris L. Egeberg A, et al. J Am Acad Dermatol. 2018 Jul;79(1):104-109.e8. doi: 10.1016/j.jaad.2018.02.074. Epub 2018 Mar 13. J Am Acad Dermatol. 2018. PMID: 29548945 Clinical Trial.

9

Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH.

Poulin Y, Crowley JJ, Langley RG, Unnebrink K, Goldblum OM, Valdecantos WC. Poulin Y, et al. Among authors: goldblum om. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):882-90. doi: 10.1111/jdv.12198. Epub 2013 Jun 22. J Eur Acad Dermatol Venereol. 2014. PMID: 23790018 Free PMC article. Clinical Trial.

10

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).

Simpson EL, Forman S, Silverberg JI, Zirwas M, Maverakis E, Han G, Guttman-Yassky E, Marnell D, Bissonnette R, Waibel J, Nunes FP, DeLozier AM, Angle R, Gamalo M, Holzwarth K, Goldblum O, Zhong J, Janes J, Papp K. Simpson EL, et al. J Am Acad Dermatol. 2021 Jul;85(1):62-70. doi: 10.1016/j.jaad.2021.02.028. Epub 2021 Feb 16. J Am Acad Dermatol. 2021. PMID: 33600915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters